{"groups":[{"description":"Participants received cemiplimab monotherapy","id":"FG000","title":"Cemiplimab"},{"description":"Participants received platinum-based doublet chemotherapy","id":"FG001","title":"Chemotherapy"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"0"}],"type":"Adverse Event"},{"reasons":[{"groupId":"FG000","numSubjects":"157"},{"groupId":"FG001","numSubjects":"184"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"10"},{"groupId":"FG001","numSubjects":"6"}],"type":"Lost to Follow-up"},{"reasons":[{"groupId":"FG000","numSubjects":"33"},{"groupId":"FG001","numSubjects":"24"}],"type":"Subject Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"1"}],"type":"Sponsor Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"6"}],"type":"Physician Decision"},{"reasons":[{"groupId":"FG000","numSubjects":"35"},{"groupId":"FG001","numSubjects":"35"}],"type":"Disease Progression"},{"reasons":[{"groupId":"FG000","numSubjects":"39"},{"groupId":"FG001","numSubjects":"56"}],"type":"Withdrawal by Subject"},{"reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"8"}],"type":"Other Than Specified"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"357"},{"groupId":"FG001","numSubjects":"355"}],"comment":"Randomized","type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"356"},{"groupId":"FG001","numSubjects":"343"}],"type":"Randomized and Treated"},{"achievements":[{"groupId":"FG000","numSubjects":"73"},{"groupId":"FG001","numSubjects":"161"}],"type":"Completed Treatment"},{"achievements":[{"groupId":"FG000","numSubjects":"75"},{"groupId":"FG001","numSubjects":"35"}],"comment":"Completed Study","type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"282"},{"groupId":"FG001","numSubjects":"320"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}